Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Diabetes, Obesity & Metabolism
|
December 20, 2018
Cost-effectiveness of intensification with sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom
Manjiri Pawaskar, S Pinar Bilir, Stacey Kowal, et al.
Current Medical Research and Opinion
|
March 31, 2017
Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting
Manjiri Pawaskar, Jinan Liu, Swapnil Rajpathak, et al.
Diabetes, Obesity & Metabolism
|
June 16, 2021
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States
Xi Tan, Lingfeng Yang, Kamlesh Khunti, et al.
Current Medical Research and Opinion
|
September 1, 2020
Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium-glucose cotransporter 2 inhibitor: a retrospective database study
Dominik Lautsch, Kristy Iglay, Lingfeng Yang, et al.
American Health & Drug Benefits
|
February 7, 2018
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use
Yuexin Tang, Xingyue Huang, Jinan Liu, et al.
Drugs & Aging
|
April 24, 2013
Sulfonylureas and risk of falls and fractures: a systematic review
Kate L Lapane, Shibing Yang, Monique J Brown, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 5, 2018
Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus
Yuexin Tang, Jinan Liu, Hakima Hannachi, et al.
Frontiers in Endocrinology
|
October 31, 2022
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Frontiers in Endocrinology
|
August 26, 2022
Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Journal of Clinical & Translational Endocrinology
|
February 26, 2020
Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis
Rajesh R Mehta, Alison M Edwards, Swapnil Rajpathak, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Diabetes, Obesity & Metabolism
|
December 20, 2018
Cost-effectiveness of intensification with sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom
Manjiri Pawaskar, S Pinar Bilir, Stacey Kowal, et al.
Current Medical Research and Opinion
|
March 31, 2017
Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting
Manjiri Pawaskar, Jinan Liu, Swapnil Rajpathak, et al.
Diabetes, Obesity & Metabolism
|
June 16, 2021
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States
Xi Tan, Lingfeng Yang, Kamlesh Khunti, et al.
Current Medical Research and Opinion
|
September 1, 2020
Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium-glucose cotransporter 2 inhibitor: a retrospective database study
Dominik Lautsch, Kristy Iglay, Lingfeng Yang, et al.
American Health & Drug Benefits
|
February 7, 2018
The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use
Yuexin Tang, Xingyue Huang, Jinan Liu, et al.
Drugs & Aging
|
April 24, 2013
Sulfonylureas and risk of falls and fractures: a systematic review
Kate L Lapane, Shibing Yang, Monique J Brown, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 5, 2018
Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus
Yuexin Tang, Jinan Liu, Hakima Hannachi, et al.
Frontiers in Endocrinology
|
October 31, 2022
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Frontiers in Endocrinology
|
August 26, 2022
Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Shangyu Chai, Ruya Zhang, Ye Zhang, et al.
Journal of Clinical & Translational Endocrinology
|
February 26, 2020
Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis
Rajesh R Mehta, Alison M Edwards, Swapnil Rajpathak, et al.
Page
of 8